Medical researchers are calling to abandon the word "cancer" in some patient-doctor conversations, to reduce anxiety and harm to patients from overtreatment. There is evidence that patients who say they have a "cancer", often choose surgery than those whose state is described by terms such as "defeat" or "abnormal cells".
"There is growing evidence that the state description using a medical label, including the use of the term" cancer "can lead to an increased preference for more invasive therapies," - says Professor Kirsten McCaffery from the University of Sydney, who - authorized the analysis BMJ colleagues Bond University and the Mayo clinic in the United States.
"A striking example of this is papillary thyroid cancer at low risk," - says Nickel Brook of the University of Sydney, who conducted the analysis.
"Studies show that the progression of clinical disease and tumor growth in patients with small papillary thyroid cancer who opt for surgical treatment, comparable to those who control their condition."
Similarly, for localized prostate cancer , Where active surveillance is the preferred management option for many years, studies show that most men still prefer to radical prostatectomy or radiation therapy.
"Although active surveillance is increasingly recognized as a safe option for the management of some patients with cancer, there is still a great belief that aggressive treatment should always be," - says Professor McCaffery.
The authors say that the cancer types that may be considered when re-naming include intrairoidalny papillary thyroid cancer (smaller than 1 cm), carcinoma of low and medium grade (DCIS), also commonly known as breast cancer stage 0 and localized prostate cancer.
"An early example of this was the fact that the World Health Organization and the International Society of Urological pathologists removed the cancer of bladder tumors. In 1998, they agreed that the state rarely passing to invasive cancer, should not be called cancer. "
This change "papilloma and carcinoma of the 1st level of the bladder" were reclassified as "papillary urothelial neoplasm of low malignant potential."
A similar change was made in labeling cervical violations detected during a Pap smear, which allowed more women to watch out for active surveillance, preferring to invasive treatments.
"The data show us that the time has come to stop talking to people with a very low risk that they have a" cancer "if they are unlikely to suffer from it", - says Dr. Ray Moynihan, a senior fellow at Bond University.